Detail page

Knowledge Web

Person

Ralf-Dieter Hofheinz (1969-)

Arzt

Name	Ralf-Dieter Hofheinz
Time	1969- (Date of birth and death)
Place	Deutschland
Academic degree	apl. Prof. Dr. med.
Profession	Arzt (characteristic profession)
Variant	R.-D. Hofheinz R. D. Hofheinz Ralf Hofheinz Ralf D. Hofheinz R. Hofheinz
Further information	Diss. Medizinische Fakultät; Oberarzt und Professor der III. Medizinischen Klinik der Medizinischen Fakultät Mannheim der Universität Heidelberg; Day Treatment Center (TTZ), Interdisciplinary Tumor Center Mannheim (ITM), Leiter
Record type	Person
GND-Identifier	121917517
Record ID	121917517
Involved in show all Multimodale Therapie des Rektumkarzinoms Clinical impact of panel gene sequencing on therapy of advanced cancers of the digestive system: a retrospective, single center study Standardisierte und qualitätsgesicherte prädiktive PD-L1-Testung im oberen Gastrointestinaltrakt Analysis of Burnout Prevalence among German Physicians Working in a Palliative Care Setting: A Survey of the AIO Quality of Life Working Group Trastuzumab in combination with 5-fluorouracil, leucovorin, oxaliplatin and docetaxel as perioperative treatment for patients with human epidermal growth factor receptor 2-positive locally advanced esophagogastric adenocarcinoma: A phase II trial of the Arbeitsgemeinschaft Internistische Onkologie Gastric Cancer Study Group Standardized and quality-assured predictive PD-L1 testing in the upper gastrointestinal tract Assessment and Evaluation of Psychosocial Distress in Outpatients with Cancer at a University Hospital in Germany Oncology in Europe Effects of a Sound Intervention on Physical and Emotional Well-Being in Patients with Cancer: A Prospective Randomized Trial Comprehensive biomarker analysis of long-term response to trastuzumab in patients with HER2-positive advanced gastric or gastroesophageal adenocarcinoma Development and validation of a predictive model for toxicity of neoadjuvant chemoradiotherapy in rectal cancer in the CAO/ARO/AIO-04 phase III trial Total Neoadjuvant Therapy for Rectal Cancer in the CAO/ARO/AIO-12 Randomized Phase 2 Trial : Early Surrogate Endpoints Revisited Verbesserung der Lebensqualität durch medikamentöse Schmerztherapie bei Patient:innen mit gastrointestinalen Tumoren Multizentrische, randomisiert-kontrollierte Studien der ACO/AIO/ARO Studien der Arbeitsgruppe Magen-Ösophagus-Tumoren der Arbeitsgemeinschaft Internistische Onkologie (AIO) Diagnostic Value of sST2, VCAM-1, and Adiponectin in Patients with Breast Cancer to Predict Anti-Tumour Treatment-Related Cardiac Events: A Pilot Study ACO/ARO/AIO-21 - Capecitabine-based chemoradiotherapy in combination with the IL-1 receptor antagonist anakinra for rectal cancer Patients: A phase I trial of the German rectal cancer study group Are we there yet? The value of deep learning in a multicenter setting for response prediction of locally advanced rectal cancer to neoadjuvant chemoradiotherapy Bedarfsermittlung von begleitender Musiktherapie als Teil des ambulanten Behandlungskonzepts von Tumorpatienten Integrative Onkologie : ein Beratungsmanual für Ärzte und Apotheker Integrative Onkologie : Ein Beratungsmanual für Ärzte und Apotheker Total neoadjuvant therapy for rectal cancer in the CAO/ARO/AIO-12 randomized phase 2 trial: early surrogate endpoints revisited International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer Analysis of end-of-life treatment and physician perceptions at a university hospital in Germany Shared Decision-Making in Oncology: Preferences in Older versus Younger Patients of an Oncology Clinic – A Conjoint Analysis Bedarfsermittlung ambulanter psychoonkologischer Betreuung Krebskranker anhand des Patientenkollektivs des Tagestherapiezentrums der Universitätsmedizin Mannheim Unfinished business: terminated cancer trials and the relevance of treatment intent, sponsors and intervention types Adding cetuximab to paclitaxel and carboplatin for first-line treatment of carcinoma of unknown primary (CUP): results of the Phase 2 AIO trial PACET-CUP RACE-trial: neoadjuvant radiochemotherapy versus chemotherapy for patients with locally advanced, potentially resectable adenocarcinoma of the gastroesophageal junction - a randomized phase III joint study of the AIO, ARO and DGAV Clinical responses to PD-1 inhibition and their molecular characterization in six patients with mismatch repair-deficient metastatic cancer of the digestive system Stellenwert und qualitative Voraussetzungen der Magnetresonanztomografie für die Therapieplanung beim lokal fortgeschrittenen Rektumkarzinom – Interdisziplinäre Empfehlungen Importance and Qualitative Requirements of Magnetic Resonance Imaging for Therapy Planning in Rectal Cancer – Interdisciplinary Recommendations of AIO, ARO, ACO and the German Radiological Society Dihydropyrimidine Dehydrogenase Testing prior to Treatment with 5-Fluorouracil, Capecitabine, and Tegafur: A Consensus Paper Dihydropyrimidine dehydrogenase testing prior to treatment with 5-Fluorouracil, Capecitabine, and Tegafur : a consensus paper Statement to an snsufficient systematic review on Viscum album L. therapy Unerwartet hohe Mortalität nach leberchirurgischen Eingriffen in Deutschland Cancer patients and music: (prospective) results from a survey to evaluate potential complementary treatment approaches Letter to the editors of the Journal of Cancer Research and Clinical Oncology Therapieassoziierte neurologische Symptome onkologischer Patienten und deren Behandlung HER2 testing in gastric cancer diagnosis: insights on variables influencing HER2-positivity from a large, multicenter, observational study in Germany Mass spectrometry based analytical quality assessment of serum and plasma specimens with patterns of endo- and exogenous peptides Does Physical Activity Improve Quality of Life in Cancer Patients Undergoing Chemotherapy? Outcome of Colorectal Cancer Patients Treated with Combination Bevacizumab Therapy: A Pooled Retrospective Analysis of Three European Cohorts from the Angiopredict Initiative A phase 2 randomised study of veliparib plus FOLFIRI±bevacizumab versus placebo plus FOLFIRI±bevacizumab in metastatic colorectal cancer Impact of adjuvant chemotherapy on patients with ypT0–2 ypN0 rectal cancer after neoadjuvant chemoradiation: a cohort study from a tertiary referral hospital Influence of complete administration of adjuvant chemotherapy cycles on overall and disease-free survival in locally advanced rectal cancer: post hoc analysis of a randomized, multicenter, non-inferiority, phase 3 trial PSA response to cabazitaxel is associated with improved progression-free survival in metastatic castration-resistant prostate cancer: the non-interventional QoLiTime study Oxaliplatin-Induced Acute ST Segment Elevation Mimicking Myocardial Infarction: A Case Report Vitamin K1 cream significantly reduces incidence and severity of cetuximab-related acneiform skin rash in women: a post hoc analysis of the EVITA trial HER2 testing in gastric cancer: results of a German expert meeting Gute Remission unter HER2-Blockade bei einem fortgeschrittenen Karzinom des ösophagogastralen Überganges bei nur fokaler HER2-Überexpression Patient preferences for palliative treatment of locally advanced or metastatic gastric cancer and adenocarcinoma of the gastroesophageal junction: a choice-based conjoint analysis study from Germany HER2-Testung beim Magenkarzinom : Ergebnisse eines deutschen Expertentreffens Peritonealkarzinose bei gastrointestinalen Malignomen Carcinoma of the colon and rectum with deregulation of insulin-like growth factor 2 signaling: clinical and molecular implications Targeted Treatment of Esophagogastric Cancer Use of Complementary and Alternative Medicine in Cancer Patients: A Prospective Questionnaire-Based Study in an Oncological Outpatient Clinic CoCStom trial: study protocol for a randomised trial comparing completeness of adjuvant chemotherapy after early versus late diverting stoma closure in low anterior resection for rectal cancer Weiterbildung Onkologie : CME-Beiträge aus: Der Onkologe Juli 2014 - Dezember 2015 Weiterbildung Onkologie : CME-Beiträge aus: Der Onkologe Juli 2014-Dezember 2015

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Ralf-Dieter Hofheinz (1969-)

Multimodale Therapie des Rektumkarzinoms

Clinical impact of panel gene sequencing on therapy of advanced cancers of the digestive system: a retrospective, single center study

Standardisierte und qualitätsgesicherte prädiktive PD-L1-Testung im oberen Gastrointestinaltrakt

Analysis of Burnout Prevalence among German Physicians Working in a Palliative Care Setting: A Survey of the AIO Quality of Life Working Group

Standardized and quality-assured predictive PD-L1 testing in the upper gastrointestinal tract

Assessment and Evaluation of Psychosocial Distress in Outpatients with Cancer at a University Hospital in Germany

Oncology in Europe

Effects of a Sound Intervention on Physical and Emotional Well-Being in Patients with Cancer: A Prospective Randomized Trial

Comprehensive biomarker analysis of long-term response to trastuzumab in patients with HER2-positive advanced gastric or gastroesophageal adenocarcinoma

Development and validation of a predictive model for toxicity of neoadjuvant chemoradiotherapy in rectal cancer in the CAO/ARO/AIO-04 phase III trial

Total Neoadjuvant Therapy for Rectal Cancer in the CAO/ARO/AIO-12 Randomized Phase 2 Trial : Early Surrogate Endpoints Revisited

Verbesserung der Lebensqualität durch medikamentöse Schmerztherapie bei Patient:innen mit gastrointestinalen Tumoren

Multizentrische, randomisiert-kontrollierte Studien der ACO/AIO/ARO

Studien der Arbeitsgruppe Magen-Ösophagus-Tumoren der Arbeitsgemeinschaft Internistische Onkologie (AIO)

Diagnostic Value of sST2, VCAM-1, and Adiponectin in Patients with Breast Cancer to Predict Anti-Tumour Treatment-Related Cardiac Events: A Pilot Study

ACO/ARO/AIO-21 - Capecitabine-based chemoradiotherapy in combination with the IL-1 receptor antagonist anakinra for rectal cancer Patients: A phase I trial of the German rectal cancer study group

Are we there yet? The value of deep learning in a multicenter setting for response prediction of locally advanced rectal cancer to neoadjuvant chemoradiotherapy

Bedarfsermittlung von begleitender Musiktherapie als Teil des ambulanten Behandlungskonzepts von Tumorpatienten

Integrative Onkologie : ein Beratungsmanual für Ärzte und Apotheker

Integrative Onkologie : Ein Beratungsmanual für Ärzte und Apotheker

Total neoadjuvant therapy for rectal cancer in the CAO/ARO/AIO-12 randomized phase 2 trial: early surrogate endpoints revisited

International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer

Analysis of end-of-life treatment and physician perceptions at a university hospital in Germany

Shared Decision-Making in Oncology: Preferences in Older versus Younger Patients of an Oncology Clinic – A Conjoint Analysis

Bedarfsermittlung ambulanter psychoonkologischer Betreuung Krebskranker anhand des Patientenkollektivs des Tagestherapiezentrums der Universitätsmedizin Mannheim

Unfinished business: terminated cancer trials and the relevance of treatment intent, sponsors and intervention types

Adding cetuximab to paclitaxel and carboplatin for first-line treatment of carcinoma of unknown primary (CUP): results of the Phase 2 AIO trial PACET-CUP

RACE-trial: neoadjuvant radiochemotherapy versus chemotherapy for patients with locally advanced, potentially resectable adenocarcinoma of the gastroesophageal junction - a randomized phase III joint study of the AIO, ARO and DGAV

Clinical responses to PD-1 inhibition and their molecular characterization in six patients with mismatch repair-deficient metastatic cancer of the digestive system

Stellenwert und qualitative Voraussetzungen der Magnetresonanztomografie für die Therapieplanung beim lokal fortgeschrittenen Rektumkarzinom – Interdisziplinäre Empfehlungen

Importance and Qualitative Requirements of Magnetic Resonance Imaging for Therapy Planning in Rectal Cancer – Interdisciplinary Recommendations of AIO, ARO, ACO and the German Radiological Society

Dihydropyrimidine Dehydrogenase Testing prior to Treatment with 5-Fluorouracil, Capecitabine, and Tegafur: A Consensus Paper

Dihydropyrimidine dehydrogenase testing prior to treatment with 5-Fluorouracil, Capecitabine, and Tegafur : a consensus paper

Statement to an snsufficient systematic review on Viscum album L. therapy

Unerwartet hohe Mortalität nach leberchirurgischen Eingriffen in Deutschland

Cancer patients and music: (prospective) results from a survey to evaluate potential complementary treatment approaches

Letter to the editors of the Journal of Cancer Research and Clinical Oncology

Therapieassoziierte neurologische Symptome onkologischer Patienten und deren Behandlung

HER2 testing in gastric cancer diagnosis: insights on variables influencing HER2-positivity from a large, multicenter, observational study in Germany

Mass spectrometry based analytical quality assessment of serum and plasma specimens with patterns of endo- and exogenous peptides

Does Physical Activity Improve Quality of Life in Cancer Patients Undergoing Chemotherapy?

Outcome of Colorectal Cancer Patients Treated with Combination Bevacizumab Therapy: A Pooled Retrospective Analysis of Three European Cohorts from the Angiopredict Initiative

A phase 2 randomised study of veliparib plus FOLFIRI±bevacizumab versus placebo plus FOLFIRI±bevacizumab in metastatic colorectal cancer

Impact of adjuvant chemotherapy on patients with ypT0–2 ypN0 rectal cancer after neoadjuvant chemoradiation: a cohort study from a tertiary referral hospital

Influence of complete administration of adjuvant chemotherapy cycles on overall and disease-free survival in locally advanced rectal cancer: post hoc analysis of a randomized, multicenter, non-inferiority, phase 3 trial

PSA response to cabazitaxel is associated with improved progression-free survival in metastatic castration-resistant prostate cancer: the non-interventional QoLiTime study

Oxaliplatin-Induced Acute ST Segment Elevation Mimicking Myocardial Infarction: A Case Report

Vitamin K1 cream significantly reduces incidence and severity of cetuximab-related acneiform skin rash in women: a post hoc analysis of the EVITA trial

HER2 testing in gastric cancer: results of a German expert meeting

Gute Remission unter HER2-Blockade bei einem fortgeschrittenen Karzinom des ösophagogastralen Überganges bei nur fokaler HER2-Überexpression

Patient preferences for palliative treatment of locally advanced or metastatic gastric cancer and adenocarcinoma of the gastroesophageal junction: a choice-based conjoint analysis study from Germany

HER2-Testung beim Magenkarzinom : Ergebnisse eines deutschen Expertentreffens

Peritonealkarzinose bei gastrointestinalen Malignomen

Carcinoma of the colon and rectum with deregulation of insulin-like growth factor 2 signaling: clinical and molecular implications

Targeted Treatment of Esophagogastric Cancer

Use of Complementary and Alternative Medicine in Cancer Patients: A Prospective Questionnaire-Based Study in an Oncological Outpatient Clinic

CoCStom trial: study protocol for a randomised trial comparing completeness of adjuvant chemotherapy after early versus late diverting stoma closure in low anterior resection for rectal cancer

Weiterbildung Onkologie : CME-Beiträge aus: Der Onkologe Juli 2014 - Dezember 2015

Weiterbildung Onkologie : CME-Beiträge aus: Der Onkologe Juli 2014-Dezember 2015